Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons, et al.
Nature (2018) Vol. 558, Iss. 7709, pp. 307-312
Open Access | Times Cited: 703

Showing 1-25 of 703 citing articles:

Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq, Christopher S. Hackett, Renier J. Brentjens
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 3, pp. 147-167
Open Access | Times Cited: 1126
‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
Stéphane Depil, Philippe Duchâteau, Stephan A. Grupp, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 185-199
Open Access | Times Cited: 889
Mechanisms of resistance to CAR T cell therapy
Nirali N. Shah, Terry J. Fry
Nature Reviews Clinical Oncology (2019)
Open Access | Times Cited: 842
Clonal hematopoiesis in human aging and disease
Siddhartha Jaiswal, Benjamin L. Ebert
Science (2019) Vol. 366, Iss. 6465
Open Access | Times Cited: 835
c-Jun overexpression in CAR T cells induces exhaustion resistance
Rachel C. Lynn, Evan W. Weber, Elena Sotillo, et al.
Nature (2019) Vol. 576, Iss. 7786, pp. 293-300
Open Access | Times Cited: 666
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
J. Joseph Melenhorst, Gregory M. Chen, Meng Wang, et al.
Nature (2022) Vol. 602, Iss. 7897, pp. 503-509
Open Access | Times Cited: 644
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Rebecca C. Larson, Marcela V. Maus
Nature reviews. Cancer (2021) Vol. 21, Iss. 3, pp. 145-161
Open Access | Times Cited: 639
Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
Zhaogang Yang, Junfeng Shi, Jing Xie, et al.
Nature Biomedical Engineering (2019) Vol. 4, Iss. 1, pp. 69-83
Open Access | Times Cited: 564
Cancer immunotherapy: Pros, cons and beyond
Shuzhen Tan, Dongpei Li, Xiao Zhu
Biomedicine & Pharmacotherapy (2020) Vol. 124, pp. 109821-109821
Open Access | Times Cited: 548
Brain immunology and immunotherapy in brain tumours
John H. Sampson, Michael D. Gunn, Peter E. Fecci, et al.
Nature reviews. Cancer (2019) Vol. 20, Iss. 1, pp. 12-25
Open Access | Times Cited: 532
Clinical lessons learned from the first leg of the CAR T cell journey
Robbie G. Majzner, Crystal L. Mackall
Nature Medicine (2019) Vol. 25, Iss. 9, pp. 1341-1355
Closed Access | Times Cited: 519
Clinical implications of T cell exhaustion for cancer immunotherapy
Andrew Chow, Karlo Perica, Christopher A. Klebanoff, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 12, pp. 775-790
Open Access | Times Cited: 512
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Mihe Hong, Justin Clubb, Yvonne Y. Chen
Cancer Cell (2020) Vol. 38, Iss. 4, pp. 473-488
Open Access | Times Cited: 486
Targeting the epigenetic regulation of antitumour immunity
Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 11, pp. 776-800
Closed Access | Times Cited: 454
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
Evan W. Weber, Kevin R. Parker, Elena Sotillo, et al.
Science (2021) Vol. 372, Iss. 6537
Open Access | Times Cited: 453
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
Qing Deng, Guangchun Han, Nahum Puebla‐Osorio, et al.
Nature Medicine (2020) Vol. 26, Iss. 12, pp. 1878-1887
Open Access | Times Cited: 445
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
Eric Shifrut, Julia Carnevale, Victoria Tobin, et al.
Cell (2018) Vol. 175, Iss. 7, pp. 1958-1971.e15
Open Access | Times Cited: 438
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
Sri Krishna, Frank J. Lowery, Amy R. Copeland, et al.
Science (2020) Vol. 370, Iss. 6522, pp. 1328-1334
Open Access | Times Cited: 418
The Emerging Landscape of Immune Cell Therapies
Evan W. Weber, Marcela V. Maus, Crystal L. Mackall
Cell (2020) Vol. 181, Iss. 1, pp. 46-62
Open Access | Times Cited: 363
Engineered T Cell Therapy for Cancer in the Clinic
Lijun Zhao, Yu Cao
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 357
CAR immune cells: design principles, resistance and the next generation
Louai Labanieh, Crystal L. Mackall
Nature (2023) Vol. 614, Iss. 7949, pp. 635-648
Closed Access | Times Cited: 339
Emerging Cellular Therapies for Cancer
Sònia Guedan, Marco Ruella, Carl H. June
Annual Review of Immunology (2018) Vol. 37, Iss. 1, pp. 145-171
Open Access | Times Cited: 325
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 724-734
Open Access | Times Cited: 310
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Molecular Therapy (2020) Vol. 28, Iss. 11, pp. 2320-2339
Open Access | Times Cited: 296
Metabolic and epigenetic regulation of T-cell exhaustion
Fabien Franco, Alison Jaccard, Pedro Romero, et al.
Nature Metabolism (2020) Vol. 2, Iss. 10, pp. 1001-1012
Closed Access | Times Cited: 286
Page 1 - Next Page

Scroll to top